Public annual accounts

Dr. Philip Jansen financials

Name: Dr. Philip Jansen financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Philip Jansen, with comparable measures and links to available source documents.

Company overview

Registry number

0726737460

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for Dr. Philip Jansen

2025 versus 2024

Operating line: €140,928
EBITDA: €137,771
Total assets: €281,922
Equity: €2,500

EBITDA margin +97.8% · Equity ratio +0.9%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€140,928	€137,771	€281,922	€2,500	-
202431 Dec 2024	€131,455	€130,929	€410,557	€2,500	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report